ResMed, Inc. is a leading healthcare company based in the United States of America. Specializing in respiratory care devices, including flow generators, masks, and accessories for sleep apnea treatment. With a medium risk ESG score of 24.7, ResMed benefits from a growing market due to increased diagnosis of sleep apnea and aging populations. The company is focusing on digital health solutions, aiming to provide clinical data for patients, medical advisors, and payers outside of hospital settings. ResMed generates most of its revenue in the Americas with a presence in Europe, Japan, and Australia.